OPKO HEALTH, INC. Logo

OPKO HEALTH, INC.

A biopharma and diagnostics firm offering novel therapies and full-service clinical lab testing.

OPK | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
4400 BISCAYNE BLVD., 33137 MIAMI
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company focused on developing and commercializing innovative healthcare solutions. The company operates through two primary segments. Its pharmaceutical division develops novel therapies, with key products including NGENLA™, a long-acting human growth hormone treatment, and RAYALDEE®. The research pipeline focuses on multispecific therapies for cancer and infectious diseases, supported by partnerships with major pharmaceutical organizations. The diagnostics division, through its subsidiary BioReference Laboratories, is one of the largest full-service clinical reference laboratories in the U.S., offering a comprehensive portfolio of testing services to physicians and patients. By integrating its therapeutic and diagnostic capabilities, OPKO aims to establish leading positions in large, growing healthcare markets and improve patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OPKO HEALTH, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPKO HEALTH, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OPKO HEALTH, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Nkarta, Inc. Logo
Developing off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America
NKTX
NKMAX Co., Ltd. Logo
Biotech firm for NK cell therapies, global research reagents, diagnostics, and supplements.
South Korea
182400
NLS Pharmaceutics Ltd. Logo
Developing therapies for rare CNS disorders, specializing in narcolepsy and sleep-wake issues.
United States of America
NLSP
NovaBay Pharmaceuticals, Inc. Logo
Develops clinically-proven anti-infective therapies for eyecare, skincare, and wound care.
United States of America
NBY
Novacyt Logo
Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.
France
ALNOV
Novartis AG Logo
Develops and markets innovative medicines globally using advanced science and technology.
Switzerland
NOVN
NOVAVAX INC Logo
Develops and commercializes nanoparticle vaccines for serious infectious diseases.
United States of America
NVAX
Develops first-in-class drugs and supplements for metabolic and fibrotic diseases.
South Korea
229500
Novo Nordisk Logo
Develops medicines and devices for chronic diseases like diabetes, obesity, and rare disorders.
Denmark
NOVO
NRX Pharmaceuticals, Inc. Logo
Develops novel oral drugs for CNS disorders, targeting suicidal depression and PTSD.
United States of America
NRXP

Talk to a Data Expert

Have a question? We'll get back to you promptly.